JUL 26, 2017 4:12 PM PDT

Immune Cells Compete Against Each Other for Survival

WRITTEN BY: Kara Marker

A study that was initially designed to simply study T cell homeostasis ended up yielding surprising results. A recently discovered cell type, innate lymphoid cells (ILCs), appeared to be better at securing proteins both ILCs and T cells need to survive. This finding is perplexing because while T cells are plentiful in the body, ILCs are extremely rare.

Innate lymphoid cells (ILCs, in gray) outcompete and exert a measurable control on the survival of the abundant T-cells (pink). This is possible because T cells decrease the number of IL-7 receptors (IL-7R, represented as butterfly nets) after binding IL-7, while ILCs do not. Credits: IBS, modified from freepiks.com

The study was a collaboration between the Institute for Basic Science, La Jolla Institute for Allergy and Immunology, and The Scripps Research Institute. Researchers are interested in understanding more about immune cell homeostasis, especially T cells and B cells, due to their vital role in vaccine effectiveness and in keeping the human body health even as it ages.

T cells need to bind a protein called interleukin-7 (IL-7) to survive, and they have an IL-7 receptor on their cell surface just for this purpose. In the past, scientists had trouble studying T cell homeostasis because it is difficult to measure levels of IL-7 in the lab. But in the current study, scientists found a way around this roadblock to study how the body regulates IL-7 production.

Starting with mice lacking any IL-7 receptors, researchers saw IL-7 proteins begin to accumulate in the mice models, since they had nothing to bind. Then, they reintroduced cells with IL-7 receptors and watched how the mice immune systems reacted. This is where they saw that T cells were not the only cell binding IL-7; ILCs were also binding IL-7 and binding it more effectively.

"To be honest, I was quite surprised that ILCs have such an effect in this model," said lead author, Christopher Martin. "Relative to T cells, there are very few ILCs in the tissues we study. So, when we were designing the initial experiments, we weren't optimistic that we would find anything interesting."

Now with ILCs in the picture, we have to wonder: Why isn’t there enough IL-7 for both these cells? Why do they need to compete? While these questions have yet to be answered, the study scientists do know why ILCs are better at binding IL-7. While T cells decrease the number of IL-7 receptors as they start to bind IL-7, ILC’s don’t, and they can continue binding IL-7 at a rate faster than T cells.

Creating healthy levels of both T cells and ILCs is important for fighting pathogens, making vaccines work, and preparing for good health in old age, when natural production of immune cells slowly diminishes. If scientists can understand why these two cell types have to compete for survival, perhaps they can find a way for both to flourish in harmony.

The present study was published in the journal Immunity.

 

Source: Institute for Basic Science

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new a ...
MAR 19, 2020
Infographics
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Top 5 Candidates for Coronavirus Vaccine Around the World
It’s easy to complain about the role of big pharma in medicine-making and the hassle of dealing with protective pa ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
Can Chinese Drug Cure COVID-19 Without Vaccine?
Researchers at China’s Peking University have announced that they are developing a treatment capable of blocking C ...
Loading Comments...